Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-mediated transcriptional modulation refers to a collection of mechanisms by which microRNAs (miRNAs), small non-coding RNAs of about 21–23 nucleotides in length, modulate gene expression at the transcriptional or post-transcriptional level. miRNAs most commonly function by binding to complementary sequences within the 3′ untranslated regions (3′ UTRs) of target messenger RNAs to induce translational repression and/or mRNA degradation. In some contexts, miRNAs also interact with promoter or enhancer regions to activate or silence gene transcription through recruitment of chromatin-modifying complexes, direct transcriptional repression, or epigenetic remodeling. These modulation processes impact cellular differentiation, proliferation, apoptosis, development, and are implicated in many diseases including cancer, inflammation, neurodegenerative, and cardiovascular disorders. However, 'microRNA-mediated transcriptional modulation' is a biological process, not a single molecule or classical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-mediated transcriptional modulation.